Benefits include slow, controlled absorption, predictable pharmacokinetics, once-weekly dosing, and minimal injection site discomfort with proper technique
If your plan denies coverage, your provider can often appeal or help you explore alternatives
This quiz covers your health history, BMI, and weight loss goals
An inter-organ neural circuit for appetite suppression
Reflecting on the clinical implications, St-Pierre says that the findings support cautious use of GLP-1 RAs in selected patients with IBD when prescribed for approved metabolic indications, with appropriate counselling and monitoring. At the same time, she noted that the findings highlight substantial evidence gaps and believes future research should move beyond proxy outcomes and incorporate prospective, IBD-specific designs that integrate objective inflammatory measures with robust metabolic phenotyping. Moreover, there should be special considerations on the effects of GLP-1 RAs on body composition of patients with IBD, she adds
Because KLOW contains multiple peptide components, each component should be verified against the batch COA for identity, amount, and purity
